Tryton Medical CEO and leadership

Carl J St Bernard is a President/CEO at CeloNova BioSciences Inc and Board Member at AdvaMed and is based in Carlsbad, California. He has worked as President/CEO at Tryton Medical; Sales at Linvatec Corporation; and Vice President, Franchise Strategic Customer Management at DePuy Synthes Companies. Carl attended Pepperdine Graziadio Business School between 1993 and 1995, Lafayette College between 1982 and 1986, and Oceanside Public Schools between 1979 and 1982.

Dr. Kaplan is an interventional cardiologist and a medical device entrepreneur. In addition to his clinical responsibilities in the Cardiac Catheterization Laboratory, Aaron supervises cardiology fellows and lectures regularly at the Tuck School. In addition, he directs the Synergy Clinician-Entrepreneur Fellowship and Clinician-MBA Scholars Program at Dartmouth. Prior to Dartmouth, Dr. Kaplan was Director of Interventional Cardiology at the Palo Alto VA/Stanford University. Dr. Kaplan has authored |70 peer-reviewed papers and serves on the Editorial Board of Cardiac Catheterization & Intervention.

Aaron founded The Dartmouth Device Symposia (3D) in 2003 to provide a forum to examine issues central to the clinical development and commercialization of medical devices. Held each fall, the Symposium brings together a small group of thought leaders from the clinical, business, governmental/regulatory, financial and legal communities. Papers emanating from the 3D Symposia have appeared in the Journal of the American Medical Association, Circulation, The Journal of the American College of Cardiology, Health Affairs, and Cardiac Catheterization and Intervention, JAMA-Cardiology.

Aaron is an active entrepreneur who has been on the founding team of a number of medical device companies including Conformal Medical, Tryton Medical, LocalMed and Perclose (acquired by Abbott). Dr. Kaplan was an Entrepreneur-In-Residence at Three Arch Partners. Aaron has |50 U.S. Patents and was inducted into the National Academy of Inventors (Class of 2015).

Dr. Kaplan received a B.S. in Engineering Sciences (Cum Laude) from Tufts University, M.D. from Wake Forest University, medical training at Northwestern University and cardiology training at Stanford University.

Brett Farabaugh has a diverse background working with entrepreneurial companies in the public and private arenas. Prior to Tryton Medical, Brett held the position of chief financial officer for StrikeIron, Inc., a venture-backed web-based data delivery company. Prior to StrikeIron, Brett served as chief financial officer of Icoria, Inc. (formerly Paradigm Genetics, Inc.), a publicly traded biotech company acquired by Clinical Data, Inc. in 2005. Brett also held the role of vice president of finance for Nuada Pharmaceuticals, Inc. Prior to joining Nuada Pharmaceuticals, he served for 12 years in various positions at PricewaterhouseCoopers (PwC), most recently as senior manager of the global technology industry group. Brett’s experience includes financial management, analysis and reporting, initial public offerings and other exit strategies, extensive due diligence related to investment and acquisitions and fundraising in both the public and private markets.

Dr. Kaplan is an interventional cardiologist and a medical device entrepreneur. In addition to his clinical responsibilities in the Cardiac Catheterization Laboratory, Aaron supervises cardiology fellows and lectures regularly at the Tuck School. In addition, he directs the Synergy Clinician-Entrepreneur Fellowship and Clinician-MBA Scholars Program at Dartmouth. Prior to Dartmouth, Dr. Kaplan was Director of Interventional Cardiology at the Palo Alto VA/Stanford University. Dr. Kaplan has authored |70 peer-reviewed papers and serves on the Editorial Board of Cardiac Catheterization & Intervention.

Aaron founded The Dartmouth Device Symposia (3D) in 2003 to provide a forum to examine issues central to the clinical development and commercialization of medical devices. Held each fall, the Symposium brings together a small group of thought leaders from the clinical, business, governmental/regulatory, financial and legal communities. Papers emanating from the 3D Symposia have appeared in the Journal of the American Medical Association, Circulation, The Journal of the American College of Cardiology, Health Affairs, and Cardiac Catheterization and Intervention, JAMA-Cardiology.

Aaron is an active entrepreneur who has been on the founding team of a number of medical device companies including Conformal Medical, Tryton Medical, LocalMed and Perclose (acquired by Abbott). Dr. Kaplan was an Entrepreneur-In-Residence at Three Arch Partners. Aaron has |50 U.S. Patents and was inducted into the National Academy of Inventors (Class of 2015).

Dr. Kaplan received a B.S. in Engineering Sciences (Cum Laude) from Tufts University, M.D. from Wake Forest University, medical training at Northwestern University and cardiology training at Stanford University.

Dr. Kaplan is an interventional cardiologist and a medical device entrepreneur. In addition to his clinical responsibilities in the Cardiac Catheterization Laboratory, Aaron supervises cardiology fellows and lectures regularly at the Tuck School. In addition, he directs the Synergy Clinician-Entrepreneur Fellowship and Clinician-MBA Scholars Program at Dartmouth. Prior to Dartmouth, Dr. Kaplan was Director of Interventional Cardiology at the Palo Alto VA/Stanford University. Dr. Kaplan has authored |70 peer-reviewed papers and serves on the Editorial Board of Cardiac Catheterization & Intervention.

Aaron founded The Dartmouth Device Symposia (3D) in 2003 to provide a forum to examine issues central to the clinical development and commercialization of medical devices. Held each fall, the Symposium brings together a small group of thought leaders from the clinical, business, governmental/regulatory, financial and legal communities. Papers emanating from the 3D Symposia have appeared in the Journal of the American Medical Association, Circulation, The Journal of the American College of Cardiology, Health Affairs, and Cardiac Catheterization and Intervention, JAMA-Cardiology.

Aaron is an active entrepreneur who has been on the founding team of a number of medical device companies including Conformal Medical, Tryton Medical, LocalMed and Perclose (acquired by Abbott). Dr. Kaplan was an Entrepreneur-In-Residence at Three Arch Partners. Aaron has |50 U.S. Patents and was inducted into the National Academy of Inventors (Class of 2015).

Dr. Kaplan received a B.S. in Engineering Sciences (Cum Laude) from Tufts University, M.D. from Wake Forest University, medical training at Northwestern University and cardiology training at Stanford University.